<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - Dangerous substances and preparations (c/m/r) - Thursday, 10 October 2002</title><meta name="title" content="Verbatim report of proceedings - Dangerous substances and preparations (c/m/r) - Thursday, 10 October 2002" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2002 - Source: European Parliament" /><meta name="available" content="10-10-2002" /><meta name="sipade-leg" content="5" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - Dangerous substances and preparations (c/m/r) - Thursday, 10 October 2002" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-5-2002-10-10-ITM-003_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li class="bg" title="bg - български">bg - български</li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-5-2002-10-10-ITM-003_ES.html">es - español</a></li>
            <li class="cs" title="cs - čeština">cs - čeština</li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-5-2002-10-10-ITM-003_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-5-2002-10-10-ITM-003_DE.html">de - Deutsch</a></li>
            <li class="et" title="et - eesti keel">et - eesti keel</li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-5-2002-10-10-ITM-003_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-5-2002-10-10-ITM-003_FR.html">fr - français</a></li>
            <li class="ga" title="ga - Gaeilge">ga - Gaeilge</li>
            <li class="hr" title="hr - hrvatski">hr - hrvatski</li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-5-2002-10-10-ITM-003_IT.html">it - italiano</a></li>
            <li class="lv" title="lv - latviešu valoda">lv - latviešu valoda</li>
            <li class="lt" title="lt - lietuvių kalba">lt - lietuvių kalba</li>
            <li class="hu" title="hu - magyar">hu - magyar</li>
            <li class="mt" title="mt - Malti">mt - Malti</li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-5-2002-10-10-ITM-003_NL.html">nl - Nederlands</a></li>
            <li class="pl" title="pl - polski">pl - polski</li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-5-2002-10-10-ITM-003_PT.html">pt - português</a></li>
            <li class="ro" title="ro - română">ro - română</li>
            <li class="sk" title="sk - slovenčina">sk - slovenčina</li>
            <li class="sl" title="sl - slovenščina">sl - slovenščina</li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-5-2002-10-10-ITM-003_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-5-2002-10-10-ITM-003_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-5-2002-10-10-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-5-2002-10-10-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-5-2002-10-10-ITM-002_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-5-2002-10-10-ITM-002_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-5-2002-10-10-ITM-004_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-5-2002-10-10-ITM-004_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-5-2002-10-10_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-5-2002-10-10_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table><table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)"></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Thursday, 10 October 2002 - Brussels</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">OJ edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 3. Dangerous substances and preparations (c/m/r) </td></tr></table>
<a name="4-046"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1538.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">President.</span></span>   – The next item is the recommendation for second reading (<a href="/doceo/document/A-5-2002-0285_EN.html">A5-0285/2002</a>) by the Committee on the Environment, Public Health and Consumer Policy, on the Council common position for adopting a European Parliament and Council Directive amending for the twenty-third time Council Directive 76/769/EEC relating to restrictions on the marketing and use of certain dangerous substances and preparations (substances classified as carcinogens, mutagens or substances toxic to reproduction) (8328/1/2002 – C5-0267/2002 – <a href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2001/0110(COD)">2001/0110(COD)</a>) (Rapporteur: Mr Nisticò). </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-047"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4749.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nisticò (PPE-DE), </span></span>  <span class="italic">rapporteur.</span> – <span class="italic">(IT)</span> Mr President, I will be very brief, for we have discussed this report at length, and just highlight new points which have emerged from a very heated debate in the Committee on the Environment, Public Health and Consumer Policy. This is actually the twenty-third amendment of Council Directive 76/769 relating to restrictions on the marketing of substances classified as carcinogens, mutagens or substances toxic to reproduction – a directive, therefore, which seeks to protect consumers’ health and to harmonise the common market in products with the same characteristics.</p>
<p class="contents">As stated in Annex I, the proposal relates to 25 new substances classified as category 2, 14 of which are considered to be carcinogens – cobalt salts, some cadmium salts, benzopyrene and some azoic dyes which have been recorded for years in literature as having carcinogenic properties have, at last, been included – three of which are considered to be mutagens and eight of which are considered to be toxic to reproduction.</p>
<p class="contents">As well as substances such as these, the ban is extended by the Commission to preparations, that is to mixtures or solutions of these substances. The Group of the Greens/European Free Alliance, particularly Mrs Schörling and a number of other Members, would like to see the ban extended to the marketing of products and articles containing these substances, such as toys, textiles or flooring, too.</p>
<p class="contents">I would stress that I am opposed to the idea of extending the ban to products as well. Consider the damage it would cause, not just in economic, commercial and industrial terms but the psychological damage too, should people learn that one of these substances – an azoic dye, for example – is present in an elegant tie, whereas, in actual fact, the carcinogenic substances are never released from that tie and the health of the person wearing it is therefore never placed at risk.</p>
<p class="contents">I will therefore confirm our position. We are opposed to Amendment No 1, tabled by Mrs Schörling, which was only endorsed by the Committee on the Environment by a very small majority and which states that ‘the Commission should extend the ban on substances classified as carcinogenic, mutagenic or toxic to reproduction...to products...’. We are also opposed to the first part of Amendment No 2 – the first seven lines – which states once again that ‘...the ban should be extended...to products...’. However, we accept the second part of Amendment No 2, which seeks to put pressure on the Commission, recommending that the Commission submit a proposal to prohibit the use of products containing mutagenic or carcinogenic substances where there is scientific evidence that these dangerous substances are actually released from the products and absorbed and accumulated by the human body in concentrations with mutagenic, carcinogenic or toxic effect.</p>
<p class="contents">I believe that this recommendation will contribute greatly to the protection of consumer health and the environment, and I hope, Mr President, that the Commission and the Council will be able to incorporate it. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-048"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/doceo/data/img/photo_generic.gif" align="right" width="50" height="63" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Wallström,</span></span>   <span class="italic">Commission</span>. – Mr President, I would like to thank the rapporteur for his constructive work. This is an important directive as it would introduce a ban on substances that have been identified and classified as carcinogens, mutagens or substances toxic to reproduction, the so-called CMR substances. It is a very far-reaching proposal as it bans the sale of these substances and all their possible mixtures to the general public. The proposed directive will therefore encourage the marketing and use of safer alternatives. Furthermore, the proposed directive provides not only for the protection of consumers' health but would also preserve the internal market. It would introduce harmonised rules throughout the Community.</p>
<p class="contents">The reasons for favouring an extension of the ban to products placed on the market for use by consumers are understandable. Nevertheless, this requires an examination of whether there is a release of the substance from the product, and whether the release is high enough to create risks for public health or the environment. This latter aspect, the determination of risk, is lacking in the proposed amendments and the Commission therefore rejects them for the time being.</p>
<p class="contents">We need to know more about the possible risks from products. I can confirm that the Commission will address the Parliament's concerns by looking into this potential problem. The Commission has already proposed to limit the risks on numerous occasions and currently, roughly 1 000 CMR substances and several thousand preparations containing CMRs are banned. One example is that of the azo-colorants that are well known carcinogens. In that case the use of such colorants was prohibited in a large number of products. However, the European Parliament insisted that oriental carpets be excluded because the release of these azo-colorants remains below acceptable thresholds. The Commission agrees because we too concluded that there was no significant risk to public health.</p>
<p class="contents">In conclusion, the Commission cannot accept Amendments Nos 1 and 2 but will consider the potential problem of CMR substances in products as a matter of urgency. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-049"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/2267.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Schörling (Verts/ALE).</span></span>   <span class="italic">(SV) </span>Mr President, this second reading is incredibly important, since it deals with the twenty-third amendment to the directive on restrictions on the marketing and use of certain dangerous substances and preparations (substances classified as carcinogens, mutagens or substances toxic to reproduction), the so-called CMR substances.</p>
<p class="contents">Neither the Council nor the Commission have wanted to meet the European Parliament halfway in our demand for the directive to include products as well. After all, products are the main source of exposure for the public, for example in toys, textiles or flooring. The risk assessment carried out in accordance with the Commission’s proposal is actually based on the precautionary principle and states clearly that the safety of the public is to be guaranteed. This can only be brought about if there is also a ban on CMR substances in consumer goods. For some obscure reason, the Commission and the Council have not wanted to accept this, despite there being scientific evidence.</p>
<p class="contents">The Council also points out that a large number of products are involved and that this is supposedly a reason for not doing anything. It should in fact be the other way round. If a large number of products contain CMR substances, we should obviously act even faster. I would have preferred to see a proposal for a ban as early as 2002, but we have not been able to get that far.</p>
<p class="contents">It is always a pleasure to work with the gentlemanly Dr Nisticò. We have been able to produce a constructive amendment, a compromise between Dr Nisticò and fellow Members from the Group of the Party of European Socialists and the Group of the Greens/European Free Alliance. I would urge fellow Members to vote in favour of Amendment No 2. We cannot wait any longer. It is irresponsible to do so, nor is it in accordance with the precautionary principle. I appeal to fellow Members: vote in favour of Amendment No 2. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-050"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1321.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Bowe (PSE).</span></span>   – Mr President, on behalf of the Socialists I welcome this report which will place serious and proper restrictions on a number of very dangerous substances that are now known to be toxic, mutagenic or carcinogenic to human beings. We must push this report through.</p>
<p class="contents">As regards the critical issue here, which is the extension of this ban to products, the Socialist Group fully supports the second amendment which proposes this idea. We recognise, of course, that further work needs to be done on this question. We must consider these products, the level of risk they present, their contact with human beings and the places where they are used. We believe, however, that this can happen further down in the legislative process. This amendment should be supported so that these discussions can take place. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-051"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1538.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">President.</span></span>   – The debate is closed.</p>
<p class="contents">The vote will take place shortly. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-052"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents" align="center"><span class="bold">IN THE CHAIR: MR DAVID MARTIN</span><br /><span class="italic">Vice-President</span></p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td></td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
